Darwin Knows

Zealand Pharma A/S

Darwin Score	+1
Ticker	ZEAL
Latest Price	375.00 DKK as of close on 04-Jul-2025
3 Month price range	353.40 to 497.00 DKK
Market Capitalisation	25.78Bn DKK
Country	Denmark
Region	Europe
Economic Sector	Health Care
Business Sector	Pharmaceuticals, Biotechnology & Life Sciences
Industry	Biotechnology
Sub-Industry	Biotechnology
Description	Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S was incorporated in 1997 and is based in Søborg, Denmark. See More ...
Company URL	https://www.zealandpharma.com

See Darwins Full Analysis for Zealand Pharma A/S

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Zealand Pharma A/S. Further information and full detail is available when you login.

TMA Part	Focus of Analysis	TMA Score
Price	Analysis of performance, trend, RSI, OBV and moving averages	+6
Sentiment	News and Candle Patterns.	0
Fundamentals	Analyst Ratings, Valuation and Dividend analysis.	-6
Flow	Institutional, Fund and Insider buying and selling.	0
Models	Forecast models.	+1

Alerts

There are 6 live alerts for Zealand Pharma A/S.

Overbought - The 5 day RSI is +81.5. (Negative)
Oversold - The 5 month RSI is +8.4. (Positive)
Oversold - The 15 month RSI is +29.4. (Positive)
The 5d moving average turned upwards 4 days ago. (Positive)
The 10d moving average turned upwards yesterday. (Positive)
The 377d moving average turned upwards yesterday. (Positive)

Peer Comparison

There are 2 peers of Zealand Pharma A/S.
Asset Name Industry Group Perf(20d)% Asset Score
Genmab A/S (GMAB) Biotechnology -7.9 -4
Novo Nordisk A/S (NOVO-B) Biotechnology -6.1 +11

Asset Name	Industry Group	Perf(20d)%	Asset Score
Genmab A/S (GMAB)	Biotechnology	-7.9	-4
Novo Nordisk A/S (NOVO-B)	Biotechnology	-6.1	+11

To see complete information on Zealand Pharma A/S or any other assets please login.

If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.